Socioeconomic inequalities in prevalence and development of multimorbidity across adulthood: A longitudinal analysis of the MRC 1946 National Survey of Health and Development in the UK.

PLoS Medicine
Amal R KhanolkarPraveetha Patalay

Abstract

We aimed to estimate multimorbidity trajectories and quantify socioeconomic inequalities based on childhood and adulthood socioeconomic position (SEP) in the risks and rates of multimorbidity accumulation across adulthood. Participants from the UK 1946 National Survey of Health and Development (NSHD) birth cohort study who attended the age 36 years assessment in 1982 and any one of the follow-up assessments at ages 43, 53, 63, and 69 years (N = 3,723, 51% males). Information on 18 health conditions was based on a combination of self-report, biomarkers, health records, and prescribed medications. We estimated multimorbidity trajectories and delineated socioeconomic inequalities (based on childhood and adulthood social class and highest education) in multimorbidity at each age and in longitudinal trajectories. Multimorbidity increased with age (0.7 conditions at 36 years to 3.7 at 69 years). Multimorbidity accumulation was nonlinear, accelerating with age at the rate of 0.08 conditions/year (95% CI 0.07 to 0.09, p < 0.001) at 36 to 43 years to 0.19 conditions/year (95% CI 0.18 to 0.20, p < 0.001) at 63 to 69 years. At all ages, the most socioeconomically disadvantaged had 1.2 to 1.4 times greater number of conditions on average c...Continue Reading

References

Nov 7, 2002·Archives of Internal Medicine·Jennifer L WolffGerard Anderson
Mar 23, 2005·Lancet·Michael Marmot
Oct 6, 2005·International Journal of Epidemiology·Michael WadsworthRebecca Hardy
Nov 21, 2007·Annals of Family Medicine·Stewart W Mercer, Graham C M Watt
Jul 1, 2009·BMJ : British Medical Journal·Jonathan A C SterneJames R Carpenter
Jan 12, 2011·Annual Review of Public Health·Sam HarperGeorge Davey Smith
Mar 16, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Chris SalisburyAlan A Montgomery
Apr 1, 2011·European Journal of Preventive Cardiology·Amal KhanolkarIlona Koupil
Jun 12, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Calypse B AgborsangayaJeffrey A Johnson
Oct 3, 2012·PloS One·Mary B PierceUNKNOWN NSHD Scientific and Data Collection Teams
Jul 20, 2014·Primary Care Diabetes·Silvia PastorinoUNKNOWN National Survey of Health and Development Scientific and Data Collection Teams
Apr 15, 2015·Experimental Gerontology·Hui-Chuan Hsu
Aug 25, 2015·Health Promotion and Chronic Disease Prevention in Canada·K C RobertsG C Jayaraman
Dec 15, 2015·AIDS and Behavior·Alexander C Tsai, Atheendar S Venkataramani
Nov 4, 2016·Preventing Chronic Disease·Kazuaki JindaiAna R Quiñones
Feb 16, 2017·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Mayilee CanizaresElizabeth M Badley
Feb 15, 2018·Australian and New Zealand Journal of Public Health·Thanya I Pathirana, Caroline A Jackson
Mar 3, 2018·Patient Related Outcome Measures·Michele PetersRay Fitzpatrick
Mar 14, 2018·Annals of Family Medicine·Stewart W MercerGraham C M Watt
Dec 10, 2019·The Lancet. Public Health·Jonathan Pearson-StuttardEdward W Gregg
Jan 1, 2020·Safety and Health at Work·Giorgione G CabralDyego L B Souza

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.